Brookline Capital Management Estimates CRSP Q2 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Brookline Capital Management reduced their Q2 2025 earnings estimates for shares of CRISPR Therapeutics in a research note issued to investors on Tuesday, May 6th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings per share of ($1.23) for the […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Brookline Capital Management reduced their Q2 2025 earnings estimates for shares of CRISPR Therapeutics in a research note issued to investors on Tuesday, May 6th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings per share of ($1.23) for the […]
